1. Home
  2. BATRA vs VERA Comparison

BATRA vs VERA Comparison

Compare BATRA & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series A

BATRA

Atlanta Braves Holdings Inc. Series A

N/A

Current Price

$54.10

Market Cap

3.7B

Sector

Industrials

ML Signal

N/A

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

N/A

Current Price

$35.05

Market Cap

3.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BATRA
VERA
Founded
1991
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.0B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
BATRA
VERA
Price
$54.10
$35.05
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$60.00
$81.30
AVG Volume (30 Days)
64.4K
1.8M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
26.00
N/A
EPS
N/A
N/A
Revenue
$732,492,000.00
N/A
Revenue This Year
$12.40
N/A
Revenue Next Year
$8.54
$472.48
P/E Ratio
N/A
N/A
Revenue Growth
10.52
N/A
52 Week Low
$41.50
$22.72
52 Week High
$58.37
$56.05

Technical Indicators

Market Signals
Indicator
BATRA
VERA
Relative Strength Index (RSI) 43.87 46.52
Support Level $53.62 $29.66
Resistance Level $56.09 $37.13
Average True Range (ATR) 1.12 1.70
MACD -0.19 0.12
Stochastic Oscillator 18.67 38.42

Price Performance

Historical Comparison
BATRA
VERA

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: